Skip Navigation Links
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Overall Recruitment Status: Enrollment on hold
 
Official Title
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
 
Region Sponsors
California - Northern
Edwards Lifesciences
 
Acronym NCT No.
MISCEND NCT02718001
 
Study Type Phase
Clinical Trial
n/a
 
Purpose
Study to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system.
 
Detailed Description
The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system.
 
 
 
Inclusion Criteria
  • Clinically significant, symptomatic mitral regurgitation
  • High risk for open-heart surgery
  • Meets anatomical criteria
 
Exclusion Criteria
  • Unsuitable anatomy
  • Patient is inoperable
 
Keywords and/or Specific Medical Conditions
  • 2013-05C
  • TMVI
  • Cardiovascular Diseases
  • TMVR
  • Heart Diseases
  • Trans-Septal
  • Heart Valve Diseases
  • Cardiology
  • Mitral Valve Insufficiency
 
KP Clinical Facility
  • San Francisco Medical Center
 
Clinical Area
  • Cardiology


Principal Investigator:
Jacob Mishell, MD
Contact Information:
- Brenda X Sudiacal, RN
-brenda.d.le@kp.org
-San Francisco Medical Center


smilelady1
Do you want to receive
Email Alerts?

Sign Up Here!